615 filings
Page 12 of 31
6-K
a8c7tqyg
27 Aug 20
Report of Foreign Private Issuer
7:10am
6-K
h74z8mn
25 Aug 20
Can-Fite Receives Notification of Patent Grant from European Patent Office for Namodenoson in the Treatment of NASH
8:22am
6-K
tfqh8yx7uxa5 4464
12 Aug 20
Current report (foreign)
4:29pm
6-K
ydotdxw
5 Aug 20
Report of Foreign Private Issuer
4:27pm
6-K
1wwlcs 62r7
27 Jul 20
Report of Foreign Private Issuer
7:09am
EFFECT
90otcz
27 Jul 20
Notice of effectiveness
12:16am
424B3
m07qj
24 Jul 20
Prospectus supplement
4:30pm
CORRESP
s9a6llcs
22 Jul 20
Correspondence with SEC
12:00am
6-K
z5up9q4g qw
20 Jul 20
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
7:10am
D
p48a8iz dm0onz3l9
17 Jul 20
$3.41M in options / securities to be acquired, sold $3.41M, 3 investors
4:30pm
UPLOAD
cnadqkqwm40lc1axne
17 Jul 20
Letter from SEC
12:00am
6-K
ioo2e76p
15 Jul 20
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
7:06am
F-1
9btceq39
10 Jul 20
Registration statement (foreign)
4:30pm
424B5
fmqqa0r0
8 Jul 20
Prospectus supplement for primary offering
10:42am
6-K
744b1yfmt4n
8 Jul 20
Report of Foreign Private Issuer
10:39am
6-K
ig4 sem4jlz6aukq
6 Jul 20
Can-Fite Announces $3.4 Million Registered Direct Offering
8:09am
6-K
osvpkqffpo byb
30 Jun 20
Report of Foreign Private Issuer
7:07am
6-K
4yu3r
29 Jun 20
Notice of Special Meeting of Shareholders
12:00am
D
xq5fvs
19 Jun 20
$8M in options / securities to be acquired, sold $8M, 4 investors
4:35pm
424B5
ju2ifn0 3a
12 Jun 20
Prospectus supplement for primary offering
8:30am